EUVIMEDOpdag EUVIMED
Kohortenstudie

The transition of metabolic phenotypes and cardiovascular events: Panasonic cohort study 16

Takahiro Ichikawa iD, Hiroshi Okada iD, Masahide Hamaguchi, Norihiro Nishioka, Yukiko Tateyama, Tomonari Shimamoto, Kazushiro Kurogi, Hiroaki Murata, Masato Ito, Taku Iwami, Michiaki Fukui

Obesity · 2024

DOI: 10.1002/oby.23999 ↗

At a glance

Kohortenstudie in Obesity, 2024. Written by Takahiro Ichikawa and 10 co-authors. Institution: Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan. Major MEDLINE topics: Phenotype, Cardiovascular Diseases. Cited 2 times so far (Crossref); 45 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

The study objective was to investigate whether changes in metabolic phenotype affect the risk of cardiovascular events.

Methods

All 117,589 participants were included in this retrospective cohort study. The metabolic phenotypes of the participants were assessed at two points (the second evaluation was set 2 years after the first evaluation), and the incidence rate of cardiovascular events was observed for 11 years. The main outcome was 3‐point major adverse cardiac events (MACE), which comprises cardiovascular death, nonfatal coronary artery disease, and nonfatal stroke incidence.

Results

Of the participants, 2748 (2.3%) cases of 3‐point MACE were identified during follow‐up. The stable metabolically healthy obesity group had a higher risk of 3‐point MACE than those with stable metabolically healthy nonobesity (MHNO). Additionally, the change from metabolically healthy obesity to MHNO for 2 years decreased the risk of 3‐point MACE (hazard ratio [HR], 1.12: 95% CI: 0.84–1.47) to the same level as stable MHNO. However, the change from metabolically abnormal nonobesity and metabolically abnormal obesity to MHNO for 2 years maintained a higher risk of 3‐point MACE (HR, 1.66 [95% CI: 1.36–2.01]; HR, 1.91 [95% CI: 1.22–2.81]) than those with stable MHNO.

Conclusions

Change in metabolic phenotype is associated with incident 3‐point MACE.

Subjects

MeSH terms (MEDLINE)

PhenotypeCardiovascular DiseasesHumansMaleFemaleMiddle AgedRetrospective StudiesIncidenceRisk FactorsObesity, Metabolically BenignAdultObesityAgedCohort Studies

Authors and institutions

  • Department of Endocrinology and Metabolism, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
  • Department of Diabetes and Endocrinology, Matsushita Memorial Hospital, Moriguchi, Japan.
  • Department of Preventive Services, Kyoto University School of Public Health, Kyoto, Japan.
  • Department of Health Care Center, Panasonic Health Insurance Organization, Moriguchi, Japan.
  • Department of Orthopaedic Surgery, Matsushita Memorial Hospital, Moriguchi, Japan.

ORCID profiles: Takahiro Ichikawa, Hiroshi Okada

Cite

APA

Ichikawa, T., Okada, H., Hamaguchi, M., Nishioka, N., Tateyama, Y., Shimamoto, T., Kurogi, K., Murata, H., Ito, M., Iwami, T., & Fukui, M. (2024). The transition of metabolic phenotypes and cardiovascular events: Panasonic cohort study 16. Obesity. https://doi.org/10.1002/oby.23999

Vancouver

Ichikawa T, Okada H, Hamaguchi M, Nishioka N, Tateyama Y, Shimamoto T, et al. The transition of metabolic phenotypes and cardiovascular events: Panasonic cohort study 16. Obesity. 2024. doi:10.1002/oby.23999

BibTeX
@article{Ichikawa2024,
  author = {Ichikawa, Takahiro and Okada, Hiroshi and Hamaguchi, Masahide and Nishioka, Norihiro and Tateyama, Yukiko and Shimamoto, Tomonari and Kurogi, Kazushiro and Murata, Hiroaki and Ito, Masato and Iwami, Taku and Fukui, Michiaki},
  title = {The transition of metabolic phenotypes and cardiovascular events: Panasonic cohort study 16},
  journal = {Obesity},
  year = {2024},
  doi = {10.1002/oby.23999}
}
Start for free →